Evaluation of Hemodynamic and Ventilatory Effects of Negative Pressure Ventilation
Launched by KARLSBURG HOSPITAL · Oct 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special breathing treatment called negative pressure ventilation affects the heart and lungs in adults who have just had heart surgery. The goal is to see if this treatment can help improve blood flow and breathing after surgery, especially in patients who have a device called a pulmonary artery catheter to monitor their heart function.
To be eligible for this trial, patients must have had heart surgery and have the pulmonary artery catheter in place. However, those who had minimally invasive surgery, are in unstable health, are experiencing bleeding, or cannot wear the special breathing device will not be able to participate. If someone joins the trial, they can expect to receive the negative pressure ventilation treatment and will be closely monitored to see how it helps their heart and lungs recover. This trial is currently looking for participants, and everyone is welcome regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with pulmonary artery catheter after cardiac surgery
- Exclusion Criteria:
- • minimally invasive surgery
- • unstable conditions
- • bleeding
- • unability to fit cuirass
About Karlsburg Hospital
Karlsburg Hospital is a distinguished healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on multidisciplinary collaboration, the hospital is committed to conducting high-quality studies that adhere to rigorous ethical standards and regulatory guidelines. By leveraging state-of-the-art facilities and a team of experienced healthcare professionals, Karlsburg Hospital aims to contribute valuable insights to the medical community, ultimately enhancing treatment options and fostering the development of new therapies for a variety of health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karlsburg, Mecklenburg Vorpommern, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported